Zanubrutinib in Patients With IgG4-Related Disease

Clinical trial NCT04602598 · COMPLETED

Trial details

NCT number: NCT04602598
Sponsor: Matthew C. Baker
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

IgG4 Related Disease

Start date: 2022-08-01
Primary completion: 2025-02-11
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.